Extrawell Pharmaceutical Schedules 30 June 2026 Board Meeting to Approve FY2026 Results
Bulletin Express
Jun 16
Extrawell Pharmaceutical Holdings Limited announced that its board of directors will convene on 30 June 2026. The primary agenda is to consider and approve the consolidated annual results for the financial year ended 31 March 2026, alongside other routine matters.
The meeting notice, dated 16 June 2026, confirms the participation of the company’s five executive directors—Dr. Xie Yi (Chairman), Dr. Guo Yi, Mr. Cheng Yong, Dr. Lou Yi and Ms. Wong Sau Kuen—and three independent non-executive directors—Ms. Jin Song, Dr. Zeng Li and Ms. Yang Xiaorong.
No additional financial figures or operational updates were disclosed in the announcement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.